Human CCDC69 ORF/cDNA clone-Lentivirus plasmid (NM_015621.3)

Cat. No.: pGMLV002711
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human CCDC69/ Lentiviral expression plasmid for CCDC69 lentivirus packaging, CCDC69 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to CCDC69 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $522.75
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLV002711
Gene Name CCDC69
Accession Number NM_015621.3
Gene ID 26112
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 891 bp
Gene Alias
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGGCTGCAGACACAGCAGGCTGAGCAGCTGCAAACCCCCGAAAAAGAAGCGCCAAGAACCAGAACCAGAACAGCCACCCAGACCAGAGCCCCATGAATTAGGTCCCCTCAATGGGGACACAGCTATAACTGTCCAGCTCTGTGCATCAGAGGAGGCTGAGCGGCACCAGAAGGATATAACCAGAATTCTCCAGCAACATGAGGAGGAAAAGAAGAAATGGGCACAACAGGTGGAGAAGGAAAGGGAGCTAGAGCTTCGAGACAGACTGGATGAGCAGCAAAGGGTCCTGGAAGGAAAGAATGAAGAGGCCCTGCAAGTCCTCCGGGCCTCATATGAACAGGAGAAAGAAGCGCTTACCCACTCTTTCCGGGAGGCCAGTTCTACCCAGCAGGAGACCATAGACAGACTGACCTCACAGCTGGAGGCTTTCCAGGCCAAAATGAAGAGGGTGGAGGAGTCCATTCTGAGCCGAAACTATAAGAAACATATCCAGGATTATGGGAGCCCCAGCCAGTTCTGGGAGCAGGAGCTGGAGAGCTTACACTTTGTCATCGAGATGAAGAATGAGCGTATTCATGAGCTGGACAGGCGGCTGATCCTCATGGAAACAGTGAAAGAGAAAAATCTGATATTGGAGGAAAAAATTACGACCCTGCAACAGGAAAATGAGGACCTCCATGTCCGAAGCCGCAACCAGGTGGTCCTGTCAAGGCAGCTGTCAGAAGACCTGCTTCTCACGCGTGAGGCCCTGGAGAAGGAGGTGCAGCTGCGGCGACAGCTCCAGCAGGAGAAGGAGGAGCTGTTGTACCGGGTCCTTGGGGCCAATGCCTCGCCTGCCTTCCCTCTGGCCCCTGTCACTCCCACTGAGGTCTCTTTCCTCGCCACATAG
ORF Protein Sequence MGCRHSRLSSCKPPKKKRQEPEPEQPPRPEPHELGPLNGDTAITVQLCASEEAERHQKDITRILQQHEEEKKKWAQQVEKERELELRDRLDEQQRVLEGKNEEALQVLRASYEQEKEALTHSFREASSTQQETIDRLTSQLEAFQAKMKRVEESILSRNYKKHIQDYGSPSQFWEQELESLHFVIEMKNERIHELDRRLILMETVKEKNLILEEKITTLQQENEDLHVRSRNQVVLSRQLSEDLLLTREALEKEVQLRRQLQQEKEELLYRVLGANASPAFPLAPVTPTEVSFLAT

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-IP2413-Ab Anti-CCDC69 monoclonal antibody
    Target Antigen GM-Tg-g-IP2413-Ag CCDC69 protein
    ORF Viral Vector pGMLV002711 Human CCDC69 Lentivirus plasmid
    ORF Viral Vector pGMPC001033 Human CCDC69 Mammalian (Non-Viral Vector) plasmid
    ORF Viral Vector vGMLV002711 Human CCDC69 Lentivirus particle


    Target information

    Target ID GM-IP2413
    Target Name CCDC69
    Gene Group Identifier
    （Target Gene ID in Homo species)         		26112
    Gene ID 101084683 (Felis catus), 138917450 (Equus caballus), 26112 (Homo sapiens), 489176 (Canis lupus familiaris)
    497906 (Rattus norvegicus), 52570 (Mus musculus), 529878 (Bos taurus), 713304 (Macaca mulatta)
    Gene Symbols & Synonyms CCDC69,Ccdc69,RGD1562251,D11Ertd461e,2210021E03Rik
    Target Alternative Names CCDC69,Coiled-coil domain-containing protein 69
    Uniprot Accession A6NI79,A6QNP9,Q3TCJ8
    Additional SwissProt Accessions: A6NI79,Q3TCJ8,A6QNP9
    Uniprot Entry Name
    Protein Sub-location Introcelluar Protein
    Category
    Disease Prostate Cancer
    Disease from KEGG
    Gene Ensembl ENSG00000198624, ENSCAFG00845005451, ENSMUSG00000049588, ENSBTAG00000002834, ENSMMUG00000050884
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.